Future studies using mouse-adapted SARS-CoV-2 mutants [57] in wild-type and Dp16 mice may clarify whether the high mortality observed in Dp16;ACE2 mice is unique to the K18-hACE2 transgene, due to Down syndrome, or is a result of the combination thereof. The gene discussed is KRT18; the disease is Down syndrome.